Coronavirus company news summary – T2 Biosystems validates molecular diagnostic test – Cancer monitoring platform converted for Covid-19

1 July 2020 (Last Updated July 1st, 2020 09:50)

Rootstock Software and Mobidiag are working together to fight against the Covid-19 pandemic. Mobidiag has developed and introduced tow Covid-19 tests, Novodiag Covid-19 for single, on-demand tests and Amplidiag Covid-19 for batch volume tests at large laboratories. The company is using Rootstock ERP, as well as Salesforce Sales Cloud and Service Cloud, to streamline the manufacturing and distribution processes.

T2 Biosystems has completed the validation of its Covid-19 molecular diagnotic test, T2SARS-CoV-2 Panel, which will now launch in the US. The test was developed under a license agreement with the Center of Discovery and Innovation at Hackensack Meridian Health.

Artificial intelligence (AI) health company TrialJectory has announced the availability of PRA Health Sciences' Health Harmony Covid-19 Monitoring Program for its global community of oncology patients. With the Health Harmony mobile app, patients can monitor and report Covid-related symptoms to their healthcare providers, ensuring a faster response should they need urgent care.

Ascom UMS has chosen Oxitone Medical as a wearable solution for remote monitoring of Covid-19 patients. The first US Food and Drug Administration (FDA) approved and CE marked wrist medical monitor, Oxitone 1000M has been integrated into Ascom's Digistat Wearables remote surveillance system.